BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25820496)

  • 1. Chondroitin Sulfate-E Binds to Both Osteoactivin and Integrin αVβ3 and Inhibits Osteoclast Differentiation.
    Miyazaki T; Miyauchi S; Anada T; Tawada A; Suzuki O
    J Cell Biochem; 2015 Oct; 116(10):2247-57. PubMed ID: 25820496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chondroitin sulfate-E on the osteoclastic differentiation of RAW264 cells.
    Miyazaki T; Miyauchi S; Tawada A; Anada T; Suzuki O
    Dent Mater J; 2010 Aug; 29(4):403-10. PubMed ID: 20610874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoactivin promotes osteoblast adhesion through HSPG and αvβ1 integrin.
    Moussa FM; Hisijara IA; Sondag GR; Scott EM; Frara N; Abdelmagid SM; Safadi FF
    J Cell Biochem; 2014 Jul; 115(7):1243-53. PubMed ID: 24415158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity.
    Sheng MH; Wergedal JE; Mohan S; Lau KH
    FEBS Lett; 2008 Apr; 582(10):1451-8. PubMed ID: 18381073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DICAM inhibits osteoclast differentiation through attenuation of the integrin αVβ3 pathway.
    Jung YK; Han SW; Kim GW; Jeong JH; Kim HJ; Choi JY
    J Bone Miner Res; 2012 Sep; 27(9):2024-34. PubMed ID: 22492581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast differentiation.
    Miyazaki T; Miyauchi S; Tawada A; Anada T; Matsuzaka S; Suzuki O
    J Cell Physiol; 2008 Dec; 217(3):769-77. PubMed ID: 18720384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice.
    Sheng MH; Wergedal JE; Mohan S; Amoui M; Baylink DJ; Lau KH
    PLoS One; 2012; 7(4):e35280. PubMed ID: 22536365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts.
    Nakano K; Okada Y; Saito K; Tanaka Y
    Arthritis Rheum; 2004 Aug; 50(8):2450-8. PubMed ID: 15334457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo.
    Frara N; Abdelmagid SM; Sondag GR; Moussa FM; Yingling VR; Owen TA; Popoff SN; Barbe MF; Safadi FF
    J Cell Physiol; 2016 Jan; 231(1):72-83. PubMed ID: 25899717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the ability of chondroitin sulfate derived from bovine, fish and pigs to suppress human osteoclast activity in vitro.
    Cantley MD; Rainsford KD; Haynes DR
    Inflammopharmacology; 2013 Dec; 21(6):407-12. PubMed ID: 23644893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linarin and its aglycone acacetin abrogate actin ring formation and focal contact to bone matrix of bone-resorbing osteoclasts through inhibition of αvβ3 integrin and core-linked CD44.
    Kim SI; Kim YH; Kang BG; Kang MK; Lee EJ; Kim DY; Oh H; Oh SY; Na W; Lim SS; Kang YH
    Phytomedicine; 2020 Dec; 79():153351. PubMed ID: 32987362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
    Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
    Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
    Yeaman C; Rapraeger AC
    J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondroitin sulfate-D promotes neurite outgrowth by acting as an extracellular ligand for neuronal integrin αVβ3.
    Shida M; Mikami T; Tamura JI; Kitagawa H
    Biochim Biophys Acta Gen Subj; 2019 Sep; 1863(9):1319-1331. PubMed ID: 31181256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dual-specific macrophage colony-stimulating factor antagonist of c-FMS and αvβ3 integrin for osteoporosis therapy.
    Zur Y; Rosenfeld L; Keshelman CA; Dalal N; Guterman-Ram G; Orenbuch A; Einav Y; Levaot N; Papo N
    PLoS Biol; 2018 Aug; 16(8):e2002979. PubMed ID: 30142160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of osteoclastic resorption activity using calcium phosphate coating combined with labeled polyanion.
    Miyazaki T; Miyauchi S; Anada T; Imaizumi H; Suzuki O
    Anal Biochem; 2011 Mar; 410(1):7-12. PubMed ID: 21078287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P; Feitsma K; Schön P; Völker W
    Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.